Boston Scientific Beats Revenue Challenges but Staggers on Eps

Boston Scientific came out swinging for its 3Q22 earnings in what can only be called a challenging time for the medtech industry.

Inflation, staffing shortages, and supply chain issues all have been part of the forecast for companies this year – but Boston Scientific seemed to weather the storm a bit better than in previous quarters.